Given that GLUT4 is an insulin‐responsive glucose transporter, the increased GLUT4 level seen in our tumour model could be either because of the direct effect of SIRT6 on Glut4 promoter or a consequence of increased plasma insulin levels or both.35 Here, INS is linked to neoplasm.